MedShield Act of 2025
- Bill Number
- S. 1085
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 1
- Policy Area
- Health
- Status
- Introduced
- Latest Action
- 2025-03-14: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Last Updated
- 2025-07-01T11:06:18Z
AI-Generated Summary
Purpose
The MedShield Act of 2025 aims to enhance U.S. pandemic preparedness and response by requiring the Secretary of Health and Human Services (HHS) to establish and implement a program called the MedShield program. This program uses artificial intelligence (AI) and other technologies to create a proactive "shield" against biological threats, both natural and man-made, drawing from lessons learned during the COVID-19 pandemic and recommendations from the National Security Commission on Artificial Intelligence (NSCAI). The goal is to enable faster, more efficient detection, response, and mitigation of pandemics without relying on emergency measures like Operation Warp Speed.
Key Provisions
- Establishment of the MedShield Program: HHS must implement the program to integrate public and private sector innovations, including from U.S. allies, for continuous monitoring and response to biological threats. It focuses on operationalizing AI to safeguard public health.
- Planning and Coordination: HHS will develop a plan to incorporate NSCAI recommendations, aligning with its role as the lead for public health and medical services under the Federal Emergency Management Agency's National Response Framework. The Secretary must consult with other federal agencies and international partners for a coordinated approach.
- AI Utilization: The program requires leveraging AI for:
- Real-time global surveillance of pathogens (disease-causing agents).
- Accelerating vaccine identification and development.
- Creating and deploying treatments for affected individuals.
- Modeling strategies for tracking pathogens, distributing vaccines, and intervening with therapies.
- Improving rapid manufacturing of vaccines and treatments.
- Reporting Requirements: Within 180 days of enactment, HHS must submit an unclassified report (with a possible classified section) to relevant congressional committees detailing the implementation plan.
- Definitions:
- "Artificial intelligence" is defined per federal law as systems that perform tasks requiring human-like intelligence.
- "MedShield" refers to a biodefense concept from the NSCAI report, akin to a protective "BioShield."
- Funding Authorization: Provides escalating appropriations to HHS for the program: $300 million in FY 2025, increasing to $500 million in FY 2029, available until spent.
Significant Changes to Existing Law
This bill introduces a new mandatory program within HHS, building on but not directly amending prior laws like the Public Health Service Act. It formalizes AI integration into pandemic response, which was not previously required at this scale, and shifts emphasis from reactive emergency declarations (e.g., under section 319 of the Public Health Service Act) to proactive, ongoing operations. It also mandates coordination with international partners, expanding beyond domestic frameworks like the National Response Framework.
Potential Impacts
- On Government Agencies: HHS gains a central leadership role in AI-driven biodefense, requiring collaboration with agencies like the Department of Defense (via NSCAI ties) and FEMA. This could streamline interagency efforts but increase administrative burdens for planning and reporting.
- On Citizens: Improves public health protection through faster pathogen detection, vaccine development, and treatment access, potentially reducing pandemic severity and economic disruption. However, widespread surveillance might raise privacy concerns, though the bill does not specify data handling.
- On International Relations: Promotes partnerships with allies for shared surveillance and response, fostering global health security and U.S. leadership in biodefense technology, which could strengthen diplomatic ties in health crises.
Main Stakeholders Affected
- Federal Government: Primarily HHS as the lead implementer; other agencies (e.g., those involved in national security and emergency response) for coordination.
- Private Sector: Companies in AI, biotechnology, pharmaceuticals, and manufacturing, as the program integrates their innovations.
- International Partners: Allied nations contributing to global surveillance and response efforts.
- Citizens and Public Health Community: U.S. residents benefit from enhanced protections; healthcare providers and researchers may participate in program activities.
- Congress: Oversight through committees on health, energy, commerce, and appropriations, influencing funding and implementation.
Notable Legal, Constitutional, or Political Implications
- Legal: Establishes enforceable requirements for AI use in public health without altering core constitutional structures, but relies on existing executive authorities under health laws. The unclassified reporting promotes transparency, while classified annexes allow handling sensitive security information.
- Constitutional: Aligns with Congress's powers to provide for the general welfare and national defense (Article I, Section 8), emphasizing proactive federal coordination without infringing on states' health roles.
- Political: Bipartisan sponsorship (Senators Rounds and Heinrich) signals broad support for AI in national security. It positions the U.S. as innovative in biodefense post-COVID, potentially influencing future budgets and international health agreements, though implementation success depends on funding and interagency buy-in. No explicit controversies are noted in the bill text.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (1)
Recent Actions
- 2025-03-14: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-03-14: Introduced in Senate
Bill Versions
- MedShield Act of 2025 — issued 2025-03-14 — PDF (6 pages)